Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus.

Ting TV, Kudalkar D, Nelson S, Cortina S, Pendl J, Budhani S, Neville J, Taylor J, Huggins J, Drotar D, Brunner HI.

J Rheumatol. 2012 Jan;39(1):174-9. doi: 10.3899/jrheum.110771. Epub 2011 Nov 15.

PMID:
22089460
2.

A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.

Carmichael SJ, Day RO, Tett SE.

Intern Med J. 2013 May;43(5):547-53. doi: 10.1111/imj.12100.

PMID:
23425382
3.

Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus.

Costedoat-Chalumeau N, Amoura Z, Hulot JS, Aymard G, Leroux G, Marra D, Lechat P, Piette JC.

Ann Rheum Dis. 2007 Jun;66(6):821-4. Epub 2007 Feb 26.

4.

Adherence to treatment in systemic lupus erythematosus patients.

Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, Le Guern V, Leroux G, Marra D, Morel N, Piette JC.

Best Pract Res Clin Rheumatol. 2013 Jun;27(3):329-40. doi: 10.1016/j.berh.2013.07.001. Review.

PMID:
24238690
5.

Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients.

Sailler L, Puissant B, Méliani P, Castex JO, Saivin S, Adoue D, Fournie B, Arlet P, Montastruc JL, Lapeyre-Mestre M, Pourrat J, Blancher A.

Ann N Y Acad Sci. 2007 Jun;1108:41-50.

PMID:
17893969
6.

Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.

Jallouli M, Galicier L, Zahr N, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Sellam J, Mariette X, Blanchet B, Hulot JS, Amoura Z, Piette JC, Costedoat-Chalumeau N; Plaquenil Lupus Systemic Study Group.

Arthritis Rheumatol. 2015 May;67(8):2176-84. doi: 10.1002/art.39194.

7.

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).

Costedoat-Chalumeau N, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin du LT, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Tanguy ML, Hulot JS, Lechat P, Musset L, Amoura Z, Piette JC; Group PLUS.

Ann Rheum Dis. 2013 Nov;72(11):1786-92. doi: 10.1136/annrheumdis-2012-202322. Epub 2012 Nov 10.

PMID:
23144449
8.

Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting.

Koneru S, Shishov M, Ware A, Farhey Y, Mongey AB, Graham TB, Passo MH, Houk JL, Higgins GC, Brunner HI.

Arthritis Rheum. 2007 Aug 15;57(6):1000-6.

9.

Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.

Costedoat-Chalumeau N, Amoura Z, Hulot JS, Hammoud HA, Aymard G, Cacoub P, Francès C, Wechsler B, Huong du LT, Ghillani P, Musset L, Lechat P, Piette JC.

Arthritis Rheum. 2006 Oct;54(10):3284-90.

10.

Hydroxychloroquine: a multifaceted treatment in lupus.

Costedoat-Chalumeau N, Dunogué B, Morel N, Le Guern V, Guettrot-Imbert G.

Presse Med. 2014 Jun;43(6 Pt 2):e167-80. doi: 10.1016/j.lpm.2014.03.007. Epub 2014 May 19. Review.

PMID:
24855048
11.

Adherence to medications in systemic lupus erythematosus.

Koneru S, Kocharla L, Higgins GC, Ware A, Passo MH, Farhey YD, Mongey AB, Graham TB, Houk JL, Brunner HI.

J Clin Rheumatol. 2008 Aug;14(4):195-201. doi: 10.1097/RHU.0b013e31817a242a.

PMID:
18636020
12.

Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.

Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, Katz P, Criswell LA, Yelin E.

Arthritis Rheum. 2009 Jan 15;61(1):13-20. doi: 10.1002/art.24091.

13.

Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI).

Yokogawa N, Kato Y, Sugii S, Inada S.

Mod Rheumatol. 2012 Apr;22(2):249-55. doi: 10.1007/s10165-011-0503-y. Epub 2011 Aug 14.

PMID:
21842436
14.

Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.

Schmajuk G, Yazdany J, Trupin L, Yelin E.

Arthritis Care Res (Hoboken). 2010 Mar;62(3):386-92. doi: 10.1002/acr.20002.

15.

Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.

Penn SK, Kao AH, Schott LL, Elliott JR, Toledo FG, Kuller L, Manzi S, Wasko MC.

J Rheumatol. 2010 Jun;37(6):1136-42. doi: 10.3899/jrheum.090994. Epub 2010 May 1.

16.

The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.

Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR.

J Rheumatol. 2013 Jun;40(6):831-41. doi: 10.3899/jrheum.120572. Epub 2013 Apr 15.

PMID:
23588942
17.

Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.

Jallouli M, Francès C, Piette JC, Huong du LT, Moguelet P, Factor C, Zahr N, Miyara M, Saadoun D, Mathian A, Haroche J, De Gennes C, Leroux G, Chapelon C, Wechsler B, Cacoub P, Amoura Z, Costedoat-Chalumeau N; Plaquenil LUpus Systemic Study Group.

JAMA Dermatol. 2013 Aug;149(8):935-40. doi: 10.1001/jamadermatol.2013.709.

PMID:
23824340
19.

Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.

Momose Y, Arai S, Eto H, Kishimoto M, Okada M.

J Dermatol. 2013 Feb;40(2):94-7. doi: 10.1111/1346-8138.12005. Epub 2012 Dec 6.

PMID:
23216212
20.

Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.

Chen YM, Lin CH, Lan TH, Chen HH, Chang SN, Chen YH, Wang JS, Hung WT, Lan JL, Chen DY.

Rheumatology (Oxford). 2015 Jul;54(7):1244-9. doi: 10.1093/rheumatology/keu451. Epub 2015 Jan 12.

PMID:
25587177
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk